ENDRA Life Sciences (NDRA) Competitors $4.39 -0.15 (-3.30%) Closing price 04:00 PM EasternExtended Trading$4.34 -0.05 (-1.14%) As of 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock NDRA vs. DHAI, BTCY, OSRH, LYRA, TNON, INBS, LUCY, ICU, CODX, and HSCSShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include DIH Holding US (DHAI), Biotricity (BTCY), OSR (OSRH), Lyra Therapeutics (LYRA), Tenon Medical (TNON), Intelligent Bio Solutions (INBS), Innovative Eyewear (LUCY), SeaStar Medical (ICU), Co-Diagnostics (CODX), and HeartSciences (HSCS). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. Its Competitors DIH Holding US Biotricity OSR Lyra Therapeutics Tenon Medical Intelligent Bio Solutions Innovative Eyewear SeaStar Medical Co-Diagnostics HeartSciences DIH Holding US (NASDAQ:DHAI) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment. Does the media favor DHAI or NDRA? In the previous week, ENDRA Life Sciences had 1 more articles in the media than DIH Holding US. MarketBeat recorded 1 mentions for ENDRA Life Sciences and 0 mentions for DIH Holding US. DIH Holding US's average media sentiment score of 0.00 beat ENDRA Life Sciences' score of -0.35 indicating that DIH Holding US is being referred to more favorably in the media. Company Overall Sentiment DIH Holding US Neutral ENDRA Life Sciences Neutral Do insiders and institutionals hold more shares of DHAI or NDRA? 27.8% of DIH Holding US shares are held by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are held by institutional investors. 49.6% of DIH Holding US shares are held by company insiders. Comparatively, 0.0% of ENDRA Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better valuation & earnings, DHAI or NDRA? DIH Holding US has higher revenue and earnings than ENDRA Life Sciences. DIH Holding US is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDIH Holding US$64.47M0.21-$8.44M-$0.30-0.95ENDRA Life SciencesN/AN/A-$11.51M-$33.89-0.13 Which has more volatility and risk, DHAI or NDRA? DIH Holding US has a beta of 0.07, indicating that its stock price is 93% less volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of -0.18, indicating that its stock price is 118% less volatile than the S&P 500. Do analysts prefer DHAI or NDRA? ENDRA Life Sciences has a consensus price target of $50.00, suggesting a potential upside of 1,038.95%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe ENDRA Life Sciences is more favorable than DIH Holding US.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DIH Holding US 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DHAI or NDRA more profitable? ENDRA Life Sciences has a net margin of 0.00% compared to DIH Holding US's net margin of -13.59%. DIH Holding US's return on equity of 0.00% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets DIH Holding US-13.59% N/A -25.97% ENDRA Life Sciences N/A -194.14%-127.89% SummaryDIH Holding US beats ENDRA Life Sciences on 9 of the 15 factors compared between the two stocks. Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NDRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.31M$7.05B$5.82B$9.74BDividend YieldN/A1.30%3.84%4.09%P/E Ratio-0.1327.1631.1525.97Price / SalesN/A145.24475.57123.18Price / CashN/A21.6837.1558.38Price / Book2.246.869.116.39Net Income-$11.51M$176.42M$3.26B$265.66M7 Day Performance-9.67%0.58%2.11%1.98%1 Month Performance-32.46%-0.45%5.12%1.33%1 Year Performance-71.82%13.07%31.25%21.15% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences2.8284 of 5 stars$4.39-3.3%$50.00+1,039.0%-71.0%$3.31MN/A-0.1320DHAIDIH Holding US0.3668 of 5 stars$0.25-7.2%N/A-91.1%$12.73M$64.47M-0.83N/ANegative NewsShort Interest ↑BTCYBiotricityN/A$0.49+11.3%N/A+14.8%$12.23M$12.06M-0.4540OSRHOSRN/A$0.59-2.4%N/AN/A$11.64MN/A0.00N/APositive NewsGap UpLYRALyra Therapeutics3.237 of 5 stars$6.67-0.4%$100.00+1,399.3%-56.2%$10.71M$1.53M-0.1150TNONTenon Medical1.6213 of 5 stars$1.38-0.7%$4.67+238.2%+198.0%$10.55M$3.28M-0.058Gap DownINBSIntelligent Bio Solutions0.3597 of 5 stars$1.44-5.3%N/A+18.5%$10.50M$3.11M0.0010Earnings ReportLUCYInnovative Eyewear0.8824 of 5 stars$2.01+2.6%N/A-47.0%$8.97M$1.64M-0.509Short Interest ↓ICUSeaStar Medical0.0966 of 5 stars$0.78+0.2%N/A-87.1%$8.70M$140K-0.222CODXCo-Diagnostics4.4422 of 5 stars$0.25-0.7%$5.50+2,078.2%-80.5%$8.54M$3.91M-0.22100Short Interest ↓Analyst RevisionHSCSHeartSciences3.2778 of 5 stars$3.73+3.9%$13.00+248.5%+3.6%$8.17MN/A-0.4010Positive News Related Companies and Tools Related Companies DIH Holding US Competitors Biotricity Competitors OSR Competitors Lyra Therapeutics Competitors Tenon Medical Competitors Intelligent Bio Solutions Competitors Innovative Eyewear Competitors SeaStar Medical Competitors Co-Diagnostics Competitors HeartSciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NDRA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access